Structural and enzymatic study of tryptophan 2,3-dioxgenase (TDO), a potential target in anticancer immunotherapy.

Research output

Research output per year 2010 2010 2011 2013

• 12 Poster
• 4 Article
• 1 Conference contribution
• 1 Paper
• 1 More
  • 1 Literature review

Research output per year

Research output per year

Search results

• 2012

  Reversal of Tumoral Immune Resistance by Inhibition of Tryptophan 2,3-Dioxygenase (TDO): Design, Synthesis and Preclinical Evaluation of a Novel TDO Inhibitor.

  Dolušić, E., Larrieu, P., Moineaux, L., Stroobant, V., Pilotte, L., Colaux, D., Van den Eynde, B., Masereel, B., Wouters, J. & Frédérick, R., 2012, In: ChemMedChem. p. 371 1 p.

  Research output: Contribution to journal › Literature review › peer-review